• Filing Date: 2021-03-31
  • Form Type: 10-K
  • Description: Annual report
v3.21.1
Description of Business (Details Narrative) - $ / shares
12 Months Ended
Oct. 16, 2020
Aug. 21, 2020
Jul. 18, 2019
Dec. 31, 2020
Dec. 31, 2019
Aug. 31, 2020
Aug. 18, 2020
Mar. 03, 2020
Common stock, par value       $ 0.02 $ .02      
Shares issued price per share     $ 15.00          
Number of newly issued shares     17,306      
DSS Securities, Inc. [Member]                
Equity ownership percentage           70.00%    
Impact BioMedical, Inc. [Member]                
Shares issued under the term of share exchange   483,334            
Common stock, par value   $ 0.02            
Shares issued price per share   $ 6.48            
Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]                
Equity ownership percentage             19.99%  
Shares issued under the term of share exchange 662,500 46,868            
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member]                
Equity ownership percentage   100.00%            
Shares issued under the term of share exchange   483,334            
Common stock, par value   $ 0.02            
Shares issued price per share   6.48            
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member] | Series A Convertible Preferred Stock [Member]                
Shares issued price per share   $ 1,000            
Number of newly issued shares   46,868            
AMRE Asset Management Inc. [Member]                
Equity ownership percentage               52.50%
American Medical Reit Inc. [Member]                
Equity ownership percentage               93.00%